The Oxford Health Company Ltd - Accounts to registrar (filleted) - small 18.2

The Oxford Health Company Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v21.1.6.35 08415762 Board of Directors 1.3.20 28.2.21 28.2.21 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure084157622020-02-29084157622021-02-28084157622020-03-012021-02-28084157622019-02-28084157622019-03-012020-02-29084157622020-02-2908415762ns16:EnglandWales2020-03-012021-02-2808415762ns15:PoundSterling2020-03-012021-02-2808415762ns11:Director12020-03-012021-02-2808415762ns11:PrivateLimitedCompanyLtd2020-03-012021-02-2808415762ns11:SmallEntities2020-03-012021-02-2808415762ns11:AuditExempt-NoAccountantsReport2020-03-012021-02-2808415762ns11:SmallCompaniesRegimeForDirectorsReport2020-03-012021-02-2808415762ns11:SmallCompaniesRegimeForAccounts2020-03-012021-02-2808415762ns11:FullAccounts2020-03-012021-02-280841576212020-03-012021-02-2808415762ns11:Director22020-03-012021-02-2808415762ns11:Director32020-03-012021-02-2808415762ns11:RegisteredOffice2020-03-012021-02-2808415762ns6:CurrentFinancialInstruments2021-02-2808415762ns6:CurrentFinancialInstruments2020-02-2908415762ns6:Non-currentFinancialInstruments2021-02-2808415762ns6:Non-currentFinancialInstruments2020-02-2908415762ns6:ShareCapital2021-02-2808415762ns6:ShareCapital2020-02-2908415762ns6:RetainedEarningsAccumulatedLosses2021-02-2808415762ns6:RetainedEarningsAccumulatedLosses2020-02-2908415762ns6:IntangibleAssetsOtherThanGoodwill2020-03-012021-02-2808415762ns6:PatentsTrademarksLicencesConcessionsSimilar2020-03-012021-02-2808415762ns6:LeaseholdImprovements2020-03-012021-02-2808415762ns6:FurnitureFittings2020-03-012021-02-2808415762ns6:IntangibleAssetsOtherThanGoodwill2021-02-2808415762ns6:LeaseholdImprovements2020-02-2908415762ns6:FurnitureFittings2020-02-2908415762ns6:LeaseholdImprovements2021-02-2808415762ns6:FurnitureFittings2021-02-2808415762ns6:LeaseholdImprovements2020-02-2908415762ns6:FurnitureFittings2020-02-2908415762ns6:LeasedAssetsHeldAsLesseens6:FurnitureFittings2020-02-2908415762ns6:LeasedAssetsHeldAsLesseens6:FurnitureFittings2020-03-012021-02-2808415762ns6:LeasedAssetsHeldAsLesseens6:FurnitureFittings2021-02-2808415762ns6:LeasedAssetsHeldAsLesseens6:FurnitureFittings2020-02-2908415762ns6:CurrentFinancialInstrumentsns6:WithinOneYear2021-02-2808415762ns6:CurrentFinancialInstrumentsns6:WithinOneYear2020-02-2908415762ns6:CurrentFinancialInstrumentsns6:WithinOneYearns6:FinanceLeases2021-02-2808415762ns6:CurrentFinancialInstrumentsns6:WithinOneYearns6:FinanceLeases2020-02-2908415762ns6:BetweenOneFiveYearsns6:FinanceLeases2021-02-2808415762ns6:BetweenOneFiveYearsns6:FinanceLeases2020-02-2908415762ns6:MoreThanFiveYearsns6:FinanceLeases2021-02-2808415762ns6:MoreThanFiveYearsns6:FinanceLeases2020-02-2908415762ns6:FinanceLeases2021-02-2808415762ns6:FinanceLeases2020-02-2908415762ns6:WithinOneYear2021-02-2808415762ns6:WithinOneYear2020-02-2908415762ns6:BetweenOneFiveYears2021-02-2808415762ns6:BetweenOneFiveYears2020-02-2908415762ns6:AllPeriods2021-02-2808415762ns6:AllPeriods2020-02-2908415762ns6:Secured2021-02-2808415762ns6:Secured2020-02-2908415762ns11:Director112020-02-2908415762ns11:Director112019-02-2808415762ns11:Director112020-03-012021-02-2808415762ns11:Director112019-03-012020-02-2908415762ns11:Director112021-02-2808415762ns11:Director112020-02-2908415762ns11:Director332020-02-2908415762ns11:Director332019-02-2808415762ns11:Director332020-03-012021-02-2808415762ns11:Director332019-03-012020-02-2908415762ns11:Director332021-02-2808415762ns11:Director332020-02-29
REGISTERED NUMBER: 08415762 (England and Wales)











Unaudited Financial Statements

for the Year Ended 28 February 2021

for

The Oxford Health Company Ltd

The Oxford Health Company Ltd (Registered number: 08415762)






Contents of the Financial Statements
for the Year Ended 28 February 2021




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


The Oxford Health Company Ltd

Company Information
for the Year Ended 28 February 2021







DIRECTORS: P J Burrows
T E G Humphrey
J E Allan





REGISTERED OFFICE: The Glades
Festival Way
Festival Park
Stoke on Trent
Staffordshire
ST15SQ





REGISTERED NUMBER: 08415762 (England and Wales)






The Oxford Health Company Ltd (Registered number: 08415762)

Statement of Financial Position
28 February 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 10,952 -
Tangible assets 5 683,382 331,390
694,334 331,390

CURRENT ASSETS
Stocks 371,630 253,413
Debtors 6 875,114 224,544
Cash at bank 314,525 54,443
1,561,269 532,400
CREDITORS
Amounts falling due within one year 7 943,677 260,659
NET CURRENT ASSETS 617,592 271,741
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,311,926

603,131

CREDITORS
Amounts falling due after more than
one year

8

(435,203

)

(96,834

)

PROVISIONS FOR LIABILITIES (89,100 ) (21,300 )
NET ASSETS 787,623 484,997

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 787,523 484,897
787,623 484,997

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The Oxford Health Company Ltd (Registered number: 08415762)

Statement of Financial Position - continued
28 February 2021


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on 6 July 2021 and were signed on its behalf by:





T E G Humphrey - Director


The Oxford Health Company Ltd (Registered number: 08415762)

Notes to the Financial Statements
for the Year Ended 28 February 2021

1. STATUTORY INFORMATION

The Oxford Health Company Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' including the provisions of Section 1A ''Small Entities'' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements cover the company as an individual entity and are presented in Pounds Sterling (£) being the functional currency.

The financial statements have been prepared on a going concern basis on the assumption that the company has adequate resources to continue in operational existence for the foreseeable future. The directors have made this assessment with regard to the company’s current and expected performance.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, after discounts, returns and rebates, excluding value added tax and other sales taxes.

Sale of goods
Turnover from the sale of goods is recognised when all the following conditions are satisfied:
- the company has transferred to the buyer the significant risks and rewards of ownership of
the goods;
- the company retains neither continuing managerial involvement to the degree usually
associated with ownership nor effective control over the goods sold;
- the amount of turnover can be measured reliably;
- it is probable that the economic benefits associated with the transaction will flow to the
company; and
- the costs incurred or to be incurred in respect of the transition can be measured reliably.

Usually, turnover from the sale of goods is recognised when the goods are delivered and legal title has passed.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Improvements to property - 20% on cost
Fixtures and fittings - 20% or 25% on cost

Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.

Government grants
Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

The Oxford Health Company Ltd (Registered number: 08415762)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2021

2. ACCOUNTING POLICIES - continued

Stocks
Stocks are stated at the lower of cost and net realisable value (estimated selling price less costs to complete and sell). Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing stock to its present location and condition. Cost is calculated using the first-in, first-out formula. Provision is made for damaged, obsolete and slow-moving stock where appropriate.

Financial instruments
Basic financial assets and liabilities are initially measured at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of future cash flows discounted at a market rate of interest. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax, if applicable. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Assets, obtained under hire purchase contracts and finance leases, are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to profit and loss account on a straight-line basis.

The Oxford Health Company Ltd (Registered number: 08415762)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2021

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 29 (2020 - 16 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
Additions 11,138
At 28 February 2021 11,138
AMORTISATION
Charge for year 186
At 28 February 2021 186
NET BOOK VALUE
At 28 February 2021 10,952

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
to and
property fittings Totals
£    £    £   
COST
At 1 March 2020 111,262 348,730 459,992
Additions 28,050 462,430 490,480
At 28 February 2021 139,312 811,160 950,472
DEPRECIATION
At 1 March 2020 22,252 106,350 128,602
Charge for year 25,100 113,388 138,488
At 28 February 2021 47,352 219,738 267,090
NET BOOK VALUE
At 28 February 2021 91,960 591,422 683,382
At 29 February 2020 89,010 242,380 331,390

The Oxford Health Company Ltd (Registered number: 08415762)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2021

5. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under finance leases are as follows:
Fixtures
and
fittings
£   
COST
At 1 March 2020 205,353
Additions 325,770
At 28 February 2021 531,123
DEPRECIATION
At 1 March 2020 46,192
Charge for year 75,807
At 28 February 2021 121,999
NET BOOK VALUE
At 28 February 2021 409,124
At 29 February 2020 159,161

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade debtors 782,823 146,748
Other debtors 92,291 77,796
875,114 224,544

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Bank loans and overdrafts 266,144 8,726
Finance leases (see note 9) 107,239 46,036
Trade creditors 384,802 120,328
Taxation and social security 173,157 40,875
Other creditors 12,335 44,694
943,677 260,659

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2021 2020
£    £   
Bank loans 214,790 40,935
Finance leases (see note 9) 220,413 55,899
435,203 96,834

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 31,667 -
Finance leases - 11,909
31,667 11,909

The Oxford Health Company Ltd (Registered number: 08415762)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2021

9. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Finance leases
2021 2020
£    £   
Net obligations repayable:
Within one year 107,239 46,036
Between one and five years 220,413 43,990
In more than five years - 11,909
327,652 101,935

Non-cancellable operating leases
2021 2020
£    £   
Within one year 1,967 2,833
Between one and five years - 2,361
1,967 5,194

10. SECURED DEBTS

The following secured debts are included within creditors:

2021 2020
£    £   
CBILS loan 190,000 -
Other loans 250,000 -
440,000 -

The CBILS loan has a debenture which is secured by way of A) a fixed charge on all properties present and future, goodwill and uncalled capital and equipment, and B) a floating charge on the undertaking and all other property and assets of the Company.

Within other loans is an invoice financing liability, this is secured on the invoice raised.

The finance leases are secured on the assets concerned.

11. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 28 February 2021 and 29 February 2020:

2021 2020
£    £   
T E G Humphrey
Balance outstanding at start of year - -
Amounts advanced 1,873 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 1,873 -

The Oxford Health Company Ltd (Registered number: 08415762)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2021

11. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

J E Allan
Balance outstanding at start of year - -
Amounts advanced 1,883 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 1,883 -

12. PENSION COMMITMENTS

The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. Contributions totalling £3,096 (2020 - £Nil) were payable to the fund at the balance sheet date and are included in creditors.